Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Genoa
Clinical trial register · Italy

Clinical Trials in Genoa, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hoffmann-La Roche28 AstraZeneca11 Sanofi10 AbbVie8 Regeneron Pharmaceuticals6
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Genoa

154 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Chiesi Farmaceutici S.p.A.
Phase 3
700
Brescia, Brindisi, Genoa, Messina, Milan, Naples, Parma, Pisa
2026-11-16
Recruiting
AstraZeneca
Phase 3
2,800
Bari, Bologna, Cosenza, Cremona, Genoa, Milan, Modena, Naples
2026-09-01
Recruiting
COLON ERDERLY LOW DOSE
NCT06840977Colon Adenocarcinoma
Matteo Clavarezza
Observational
51
Genova, Genoa
2026-07-07
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Bologna, Genoa, Brescia, Milan, Perugia, Messina, Ancorna, Pisa
2026-05-21
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
NCT07285655Pulmonary Hypertension Due to Lung Disease (Disorder)
Liquidia Technologies, Inc.
Phase 3
344
Genoa, Rome
2026-04-23
Active, closed
Novo Nordisk A/S
Phase 3
606
Ferrara, Genoa, Pavia, Palermo, Padova, Verona, Bologna, Rozzano (MI)
2026-04-21
Recruiting
Mediar Therapeutics
Phase 2
85
Ancona, Catania, Genoa, Milan, Modena, Roma
2026-04-16
Recruiting
Transition to KPL-387 Monotherapy Dosing & Administration Study
NCT07288216Recurrent Pericarditis, Heart Diseases, Pericarditis
DrugKPL-387
Kiniksa Pharmaceuticals International, plc
Phase 2
120
Florence, Genoa, Milan, Padua, Udine, Varese
2026-03-25
Recruiting
Hoffmann-La Roche
Phase 2
360
Chieti, Naples, Salerno, Roma, Genoa, Milan, Pavia
2026-03-10
Recruiting
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
NCT07159841Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia
DrugAtumelnant
Crinetics Pharmaceuticals Inc.
Phase 2/3
153
Naples, Genoa, Milan, Florence
2026-01-22
Recruiting
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
NCT06654882Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
DrugsAbatacept·Tofacitinib·Tocilizumab
Duke University
Phase 3
400
Genoa
2026-01-09
Recruiting
Ente Ospedaliero Ospedali Galliera
Observational
25
Genoa
2025-12-02
Recruiting
Hoffmann-La Roche
Phase 3
900
Naples, Salerno, Bologna, Cassino, Rome, Genoa, Brescia, Milan
2025-11-24
Recruiting
ADRIS Driving Simulator for Adolescents With Attention Deficit and Hyperactivity Disorder
NCT07478458ADHD - Attention Deficit Disorder With Hyperactivity
Istituto Giannina Gaslini
Not applicable
120
Genoa, Pisa
2025-11-10
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Naples, Bologna, Aviano, Rome, Genoa, Bergamo, Milan, Monza
2025-11-03
Active, closed
Ambra Bisio
Not applicable
39
Genoa
2025-11-02
Recruiting
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
NCT07194850Immune Thrombocytopenia (ITP), ITP - Immune Thrombocytopenia, ITP, Immune Thrombocytopenic Purpura
DrugEfgartigimod
argenx
Phase 2/3
24
Genoa, Monza, Roma, Torino
2025-10-20
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Bari, Genoa, Rome, Pisa, Castelfranco Veneto, Milan, Naples, Parma
2025-09-30
Recruiting
Jazz Pharmaceuticals
Phase 2
125
Milan, Bologna, Genoa, Misterbianco, Monza
2025-09-24
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Rome, Genoa, Brescia, Milan
2025-09-17
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Naples, Bologna, Aviano, Genoa, Pontedera, Prato, Milan, Novara
2025-09-11
Not yet open
Efficacy and Tolerability of Low-Dose Enzalutamide in Prostate Cancer
NCT06718647Prostate Cancer Metastatic Disease
Monica Boitano
Observational
150
Genoa
2025-09-01
Recruiting
Sanofi
Phase 3
90
Florence, Genoa, Milan, Naples, Meldola, Novara, Palermo, Trieste
2025-08-18
Recruiting
Sanofi
Phase 3
723
Florence, Genoa, Milan, Rome, Turin, Bologna, Messina, Novara
2025-08-06
Recruiting
AstraZeneca
Phase 3
700
Arezzo, Bari, Bergamo, Chieti, Genoa, Milan, Naples, Palermo
2025-08-06
Recruiting
Kiniksa Pharmaceuticals International, plc
Phase 2/3
325
Florence, Genoa, Milan, Padua, Turin, Udine, Varese
2025-07-25
Recruiting
Hoffmann-La Roche
Observational
700
Lecce, Naples, Modena, Ravenna, Rome, Genoa, Bergamo, Milan
2025-07-15
Recruiting
Takeda
Phase 3
347
Bologna, Brescia, Genoa, Messina, Milan, Pavia, Piacenza, Torino
2025-07-15
Recruiting
Hoffmann-La Roche
Phase 3
80,000
Naples, Rome, Genoa, Brescia, Milan, Palermo, Perugia
2025-07-02
By invitation
BioMarin Pharmaceutical
Phase 3
140
Genoa, Rome
2025-06-20
Recruiting
MediWound Ltd
Phase 3
216
Brindisi, Naples, Genoa, Pisa, Padova, Roma
2025-06-01
Recruiting
Eikon Therapeutics
Phase 2/3
740
San Giovanni Rotondo, Alessandria, Messina, Milan, Modena, Padova, Trento, Genoa
2025-05-22
Recruiting
Shockwave™Peripheral Intravascular Lithotripsy Balloon for Advanced Endovascular Aortic Repair
NCT06332911Thoracoabdominal Aortic Aneurysm, Without Mention of Rupture, Abdominal Aortic Aneurysm Without Rupture, Thoracic Aortic Aneurysm Without Rupture
Rede Optimus Hospitalar SA
Observational
30
Genoa, Verona
2025-05-19
Recruiting
Penumbra Inc.
Observational
300
Brescia, Genoa
2025-05-18
Recruiting
Biogen
Phase 3
454
Bari, Fontevivo, Modena, Piacenza, Trieste, Genoa, Brescia, Ranica
2025-05-08
Recruiting
Unmet Needs Among Patients With Isolated REM Sleep Behavior Disorder (iRBD) and Their Significant Others
NCT07498452REM Sleep Behavior Disorder, Isolated REM Sleep Behavior Disorder
Universita di Verona
Observational
150
Bologna, Genoa, Milan, Pavia, Cagliari, Troina, Pisa, Verona
2025-05-06
Recruiting
Epygenix
Phase 3
260
Genoa, Pozzilli, Catanzaro, Florence, Milan, Pavia
2025-04-09
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
300
Genoa, Milan, Rozzano, Rome, Pavia, Pisa
2025-04-01
Active, closed
Sanofi
Phase 2
204
Genoa, Milan, Rozzano, Naples, Padua, Rome, Turin, Alessandria
2025-03-28
Recruiting
AstraZeneca
Phase 3
400
Bari, Bergamo, Brescia, Cagliari, Catanzaro, Genoa, Milan, Modena
2025-03-28
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 3
340
Aviano, Bari, Brescia, Crema, Cremona, Florence, Genoa, Meldola
2025-03-27
Recruiting
AstraZeneca
Phase 2
540
Catania, Foggia, Genoa, Roma
2025-03-26
Recruiting
AstraZeneca
Phase 3
5,000
Bassano del Grappa, Bologna, Desio, Foggia, Genoa, Modena, Naples, Novara
2025-03-03
Recruiting
Ospedale Policlinico San Martino
Observational
1,200
Genoa
2025-02-28
Recruiting
Menarini Group
Phase 2
44
Bari, Bologna, Genoa, Parma, Rome, Torino
2025-02-18
By invitation
Longboard Pharmaceuticals
Phase 3
324
Florence, Genoa, Milan, Pavia, Rome, Verona
2025-02-12
Active, closed
Sanofi
Phase 3
231
Cona, Florence, Genoa, Milan, Padua, Rome, Bologna
2025-02-12
Recruiting
GE Healthcare
Phase 4
50
Bergamo, Genoa
2025-01-20
Recruiting
Fondazione Italiana Sclerosi Multipla
Not applicable
30
Rome, Genoa
2025-01-15
Not yet open
Istituto Giannina Gaslini
Phase 4
166
Genoa
2025-01-01
Recruiting
Basilea Pharmaceutica
Phase 3
450
Cuneo, Genoa, Milan, Modena, Pavia, Pisa, Siena, Trieste
2024-12-11
By invitation
Mario Stirpe
Observational
400
Milan, Novara, Rome, Sassari, Genoa
2024-11-14
Active, closed
Longboard Pharmaceuticals
Phase 3
367
Florence, Genoa, Milan, Pavia, Rome, Verona
2024-11-11
Active, closed
Sanofi
Phase 2
556
Torette, Monserrato, Cona, Genoa, Milan, Rozzano, Rome, Bergamo
2024-11-07
Recruiting
Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program
NCT06636383Glycogen Storage Disease Type Ia
Ultragenyx Pharmaceutical Inc
Observational
140
Naples, Genoa
2024-11-04
Active, closed
Longboard Pharmaceuticals
Phase 3
96
Florence, Genoa, Pavia, Rome, Verona
2024-09-25
Active, closed
Hoffmann-La Roche
Phase 3
338
Bari, Parma, Rome, Genoa, Sassari, Florence, Pisa, Padova
2024-09-23
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Meldola, Genoa, Milan, Alessandria, Ascoli Piceno, Pavia, Ravenna
2024-09-16
Active, closed
AstraZeneca
Phase 2
194
Genoa, Meldola, Milan, Naples, Orbassano, Perugia, Rozzano, Udine
2024-08-27
By invitation
Ospedale Policlinico San Martino
Observational
400
Genoa
2024-08-01
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Chieti, Catanzaro, Naples, Bologna, Rome, Genoa, Milan, Pavia
2024-07-30
Active, closed
GRIN Therapeutics, Inc.
Phase 1/2
30
Genoa, Florence, Roma
2024-07-10
Active, closed
BioMarin Pharmaceutical
Phase 3
80
Genoa, Rome
2024-06-17
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Chieti, Catanzaro, Naples, Bologna, Rome, Genoa, Milan, Pavia
2024-05-13
Recruiting
AstraZeneca
Phase 3
675
Bergamo, Genoa, Milan, Monza, Padova, Pavia, Ravenna, Roma
2024-04-11
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Rome, Genoa, Milan, Naples
2024-03-28
Recruiting
AstraZeneca
Phase 3
5,250
Ancona, Florence, Genoa, Mestre, Milan, Naples, Pavia, Perugia
2024-02-21
Recruiting
Current Practice of Ventilation Strategies in Children Undergoing General Anesthesia
NCT06166706Mechanical Ventilation Complication, Pediatric ALL, Pulmonary Complication, Perioperative/Postoperative Complications
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Observational
10,000
Genoa
2024-01-29
Active, closed
Sanofi
Phase 3
260
Torette, Genoa, Milan, Rozzano, Rome, Turin, Bergamo, Bologna
2024-01-23
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Meldola, Genoa, Monza, Turin, Aviano, Candiolo, Bologna, Brescia
2023-12-28
Active, closed
Sanofi
Phase 3
943
Augusta, Cona, Florence, Genoa, Milan, Naples, Cefalù, Rome
2023-12-27
Active, closed
Sanofi
Phase 3
1,655
Cona, Florence, Genoa, Milan, Monza, Naples, Rome, Orbassano
2023-12-13
Recruiting
Regeneron Pharmaceuticals
Phase 3
822
Meldola, Tricase, Genoa, Candiolo, Ascoli Piceno, Bologna, Brescia, Milan
2023-12-12
By invitation
L-AmB_ Retrospective mUlticenter Study on Mycosis prOphylaxis
NCT06640296Invasive Fungal Infections, Prophylaxis, Invasive Fungal Disease
DrugLiposomal Amphotericin B
Istituto Giannina Gaslini
Observational
120
Genoa
2023-12-12
Recruiting
AbbVie
Phase 3
110
Genoa, Naples, Rome, Messina
2023-12-11
Recruiting
BioMarin Pharmaceutical
Observational
400
Genoa, Roma, Milan, Rome
2023-11-27
Active, closed
AstraZeneca
Phase 3
1,898
Bari, Genoa, Meldola, Milan, Naples, Padova, Rome, Rozzano
2023-11-21
Active, closed
AstraZeneca
Phase 3
1,835
Bergamo, Bologna, Foggia, Genoa, Naples, Pisa, Roma, Torino
2023-11-07
Active, closed
AstraZeneca
Phase 3
5,511
Bergamo, Bologna, Florence, Genoa, Meldola, Milan, Misterbianco, Monza
2023-10-05
Recruiting
AbbVie
Phase 3
90
Florence, Genoa
2023-10-02
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Tricase, Genoa, Rozzano, Lombardy, Giugliano in Campania, Bari, Pozzuoli (NA), Lugo
2023-09-22
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
San Giovanni Rotondo, Meldola, Genoa, Alessandria, Turin, Candiolo, Ancona, Bologna
2023-09-18
Active, closed
Hoffmann-La Roche
Phase 3
1,130
Naples, Bologna, Modena, Genoa, Bergamo, Milan, Rozzano, Catania
2023-09-18
Active, closed
Hoffmann-La Roche
Phase 3
687
Tricase, Bologna, Rome, Genoa, Rozzano, Palermo, Verona
2023-09-14
Active, closed
Hoffmann-La Roche
Phase 3
459
Bari, Naples, Bologna, Rome, Genoa, Pavia, Turin
2023-08-08
Recruiting
Kartos Therapeutics, Inc.
Phase 2/3
268
Catania, Forlì, Genoa, Lecco, Lucca, Milan, Parma, Piacenza
2023-07-17
Recruiting
H. Lundbeck A/S
Phase 3
315
Cagliari, Genoa, Milan, Pavia, Pisa, Rome
2023-06-08
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Genoa, Milan, Turin, Rome, Florence, Padova
2023-05-31
Recruiting
Pfizer
Phase 2
100
Naples, Genoa, Monza, Rome, Catania, Padova, Pavia, Torino
2023-05-17
Active, closed
Metformin and Nightly Fasting in Women With Early Breast Cancer
NCT05023967Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma
DrugsGlucophage·Metformin Hydrochloride
M.D. Anderson Cancer Center
Phase 2
120
Genoa, Milan
2023-04-04
Active, closed
Bayer
Phase 3
985
Foggia, Naples, Bologna, Modena, Reggio Emilia, Aviano, Rome, Genoa
2023-04-03
Active, closed
Hoffmann-La Roche
Phase 3
85
Genoa, Turin
2023-03-29
Active, closed
AbbVie
Phase 3
520
Florence, Meldola, Genoa, Rozzano, Milan, Naples, Rome, Mirano
2023-03-15
Recruiting
FDG-PET in the Diagnosis of Autoimmune Encephalitis
NCT06019975Autoimmune Encephalitis
University of Milano Bicocca
Observational
90
Udine, Genoa, Pavia, Milan, Monza
2023-03-01
Recruiting
Pfizer
Phase 3
100
Genoa, Rozzano, Rome, Parma, Torino
2022-12-09
Active, closed
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
NCT05476926Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion
DrugsVabysmo·Faricimab
Hoffmann-La Roche
Observational
6,000
Chieti, Bari, Catanzaro, Naples, Udine, Rome, Genoa, Bergamo
2022-11-21
Active, closed
Regeneron Pharmaceuticals
Phase 3
63
Genoa
2022-11-21
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Naples, Modena, Rome, Genoa, Milan, Pavia, Turin, Florence
2022-10-14
Active, closed
Hoffmann-La Roche
Phase 3
122
Naples, Genoa, Pavia, Palermo
2022-09-27
Active, closed
GlaxoSmithKline
Phase 3
3,038
Genoa, Milan
2022-08-10
Active, closed
Genentech, Inc.
Phase 3
373
Modena, Rome, Genoa, Milan, Torrette Di Ancona, Verona
2022-08-03
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Naples, San Giovanni Rotondo, Genoa, Rozzano, Candiolo, Pisa, Bari, Brescia
2022-07-14
Active, closed
Hoffmann-La Roche
Phase 2/3
97
Rome, Genoa, Milan, Ancona
2022-06-02
Recruiting
Hoffmann-La Roche
Phase 2
40
Rome, Genoa, Milan
2022-05-12
Active, closed
Hoffmann-La Roche
Phase 3
1,300
Gallarate, Ponderano, Rome, Genoa, Milan, Montichiari, Orbassano, Cefalù
2022-05-03
Recruiting
SK Life Science, Inc.
Phase 3
252
Genoa, Milan, Verona, Florence
2022-04-28
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Naples, Genoa, Monza (MB), Catania (CT), Torrette, Trento, Livorno, Prato
2022-03-07
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
NCT04988555Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute, Multiple Myeloma, Myelodysplastic Syndromes
DrugsAzoles·Gilteritinib·Azacitidine·Venetoclax
Sumitomo Pharma America, Inc.
Phase 1/2
606
Bologna, Busto Arsizio, Genoa, Meldola, Padua, Perugia, Ravenna, Rome
2022-02-28
Active, closed
Agios Pharmaceuticals, Inc.
Phase 2/3
286
Naples, Modena, Rome, Genoa, Palermo
2022-02-11
Recruiting
H. Lundbeck A/S
Phase 3
600
Rome, Genoa, Milan, Cagliari, Florence, Pisa, Pavia
2021-12-01
Active, closed
Hoffmann-La Roche
Phase 3
660
Ravenna, Genoa, Milan, Torrette Di Ancona
2021-11-18
Recruiting
Pfizer
Phase 3
245
Genoa, Rozzano, Roma, Milan
2021-11-17
Active, closed
AbbVie
Observational
873
Bari, Catania, Genoa, Messina, Milan, Turin, Roma, Cava de' Tirreni
2021-11-17
Active, closed
Hoffmann-La Roche
Phase 3
83
Rome, Genoa
2021-10-22
Active, closed
Eli Lilly and Company
Phase 3
874
Naples, Aviano, Rome, Genoa, Florence, Padova
2021-10-04
Active, closed
Hoffmann-La Roche
Phase 3
217
Rome, Genoa, Orbassano, Padova
2021-09-30
Active, closed
Hoffmann-La Roche
Phase 1/2
42
Genoa, Milan, Turin
2021-09-14
Active, closed
Spanish Breast Cancer Research Group
Phase 3
27
Alessandria, Ancona, Bolzano, Castellanza, Catania, Cremona, Florence, Genoa
2021-09-14
Recruiting
Bristol-Myers Squibb
Phase 3
102
Genoa, Milan, Torino
2021-07-21
Recruiting
H. Lundbeck A/S
Phase 3
285
Pavia, Rome, Milan, Cagliari, Genoa
2021-06-30
Active, closed
Incyte Corporation
Phase 3
899
Bergamo, Brescia, Candiolo, Catania, Forlì, Genoa, Lecce, Milan
2021-05-11
Active, closed
Hoffmann-La Roche
Observational
800
Taranto, Reggio Calabria, Meldola, Rome, Genoa, Brescia, Cremona, Novara
2021-05-10
Active, closed
Hoffmann-La Roche
Phase 2
586
Naples, Salerno, Bologna, Rome, Genoa, Brescia, Milan, Pozzilli (IS)
2021-05-05
Active, closed
Hoffmann-La Roche
Phase 3
761
Naples, Bologna, Meldola, Rome, Genoa, Milan, Orbassano, Arezzo
2021-05-03
Active, closed
Sarepta Therapeutics, Inc.
Observational
205
Genoa, Padova, Milan
2021-04-22
Active, closed
Eli Lilly and Company
Phase 3
101
Naples, Genoa, Milan, Florence, Brescia
2021-04-13
Active, closed
Hoffmann-La Roche
Phase 3
751
Chieti, Bari, Naples, Rome, Genoa, Milan, Montichiari, Pavia
2021-03-24
Active, closed
ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)
NCT05388708Acute Respiratory Distress Syndrome, Extracorporeal Membrane Oxygenation
University of Michigan
Observational
550
Genoa
2021-02-04
Recruiting
SCAD : a Registry of Spontaneous Coronary Artery Dissection
NCT06601270Spontaneous Coronary Artery Dissection
European Society of Cardiology
Observational
1,500
Bergamo, Foggia, Genoa, Mantua, Milan, Monza
2021-01-30
Active, closed
Bayer
Phase 4
654
Ferrara, Modena, Parma, Aviano, Rome, Genoa, Milan, Alessandria
2020-11-09
Active, closed
Hoffmann-La Roche
Phase 3
985
Naples, Parma, Rome, Genoa, Milan, Montichiari, Pozzilli, Palermo
2020-10-26
Active, closed
AbbVie
Phase 3
527
Bologna, Genoa, Milan, Rho, Rome, Negrar, Cagliari, Palermo
2020-09-30
Active, closed
Hoffmann-La Roche
Phase 3
271
Bari, Genoa, Brescia, Florence, Padova
2020-08-10
Active, closed
Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial
NCT03947619ST Elevation (STEMI) Myocardial Infarction of Anterior Wall
Abiomed Inc.
Not applicable
527
Genoa, Milan, Verona, Rozzano
2019-12-12
Recruiting
Celgene
Phase 2
99
Rome, Genoa, Naples, Orbassano
2019-11-07
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Florence, Allessandria, Bologna, Brindisi, Cagliari, Ferrara, Genoa, Lecce
2019-08-12
Active, closed
Hoffmann-La Roche
Phase 3
1,013
Naples, Rome, Genoa, Milan, Pavia, Orbassano, Cefalù
2019-08-12
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
DrugsPonatinib·Imatinib·Cytarabine·Vincristine
Takeda
Phase 3
245
Meldola, Genoa, Monza, Reggio Emilia, Mestre, Bologna, Lecce, Milan
2018-10-04
Active, closed
AbbVie
Phase 3
1,242
Genoa, Rozzano, Milan, Rho, Rome, Negrar, Bologna, Catania
2018-08-28
Active, closed
Gilead Sciences
Phase 2
502
Arezzo, Aviano, Cremona, Genoa, Meldola, Milan, Novara, Padova
2018-08-13
Recruiting
Sanofi
Phase 2
51
Genoa, Milan, Rome
2018-08-09
Active, closed
Hoffmann-La Roche
Phase 3
927
Bari, Naples, Trieste, Rome, Genoa, Milan, Pavia, Pozzilli
2018-05-28
Active, closed
Pyruvate Kinase Deficiency Global Longitudinal Registry
NCT03481738Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc.
Observational
500
Pescara, Naples, Genoa, Milan, Roma
2018-04-23
Active, closed
AbbVie
Phase 3
1,336
Torrette, Genoa, Rozzano, Milan, Rho, Rome, Florence, Negrar
2018-04-09
Active, closed
Y-mAbs Therapeutics
Phase 2
122
Genoa, Milan, Rome
2018-04-03
Active, closed
Hoffmann-La Roche
Phase 3
382
Naples, Modena, Rome, Genoa, Milan, Monza, Novara, Orbassano
2017-09-20
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Ferrara, Florence, Genoa, Grosseto, Legnago, Meldola, Milan, Monza
2015-08
Active, closed
Eli Lilly and Company
Phase 3
493
Brindisi, Cona, Genoa, Candiolo, Prato, Negrar, Bergamo, Bologna
2014-11-06
Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
NCT01633489Lysosomal Acid Lipase Deficiency, Cholesterol Ester Storage Disease, Wolman Disease, Acid Cholesteryl Ester Hydrolase Deficiency, Type 2
Alexion Pharmaceuticals, Inc.
Observational
300
Bari, Naples, Udine, Genoa, Bergamo, Milan, Turin, Florence
2013-05-30
Active, closed
AbbVie
Observational
8,250
Bologna, Florence, San Giovanni Rotondo, Genoa, Rozzano, Milan, Naples, Rome
2013-04-29
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bologna, Florence, Genoa, Monza, Naples, Padova, Pavia, Pisa
2013-04
Recruiting
PREgnancy and FERtility Registry
NCT02895165Breast Neoplasms, Pregnancy, Fertility Preservation
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Observational
1,000
Asti, Brindisi, Monserrato, Cuneo, Cona, Genoa, Lecce, Lido di Camaiore
2012-11
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Milan, Bari, Bologna, Genoa, Naples, Rome
2012-07
Active, closed
Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up
NCT01357772Carcinoma, Intraductal, Noninfiltrating, Recurrence, Local Neoplasm, Breast Neoplasms, Atypical Hyperplasia
DrugTamoxifen
Andrea DeCensi
Phase 3
500
Tortona, Meldola, Carpi, Bari, Catanzaro, Genoa, Milan, Modena
2008-11-12
Rows per page Showing 1–154 of 154
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/genoa

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 154 of those studies with a site in Genoa.

How many clinical trials are recruiting in Genoa?

72 of the 154 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 72 are active but closed to new participants, and 7 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Genoa), 154 studies
PhaseStudiesRecruitingShare
Phase 3863355.8%
Observational261516.9%
Phase 2191112.3%
Phase 2/31297.8%
Not applicable422.6%
Phase 1/2412.6%
Phase 4311.9%

Most active sponsors

Lead sponsors with the most studies (Genoa)
Lead sponsorStudiesRecruiting
Hoffmann-La Roche285
AstraZeneca117
Sanofi103
AbbVie82
Regeneron Pharmaceuticals64
Bayer30
BioMarin Pharmaceutical31
Bristol-Myers Squibb33
Eli Lilly and Company30
H. Lundbeck A/S33
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.